HGHVX | VHCIX | HGHVX / VHCIX | |
Total Expense Ratio | 0.91 | 0.09 | 1,011% |
Annual Report Gross Expense Ratio | 0.91 | 0.09 | 1,011% |
Fund Existence | 6 years | 21 years | - |
Gain YTD | -7.786 | -5.249 | 148% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 824M | 19.2B | 4% |
Annual Yield % from dividends | 0.46 | 1.51 | 31% |
Returns for 1 year | -15.06 | -8.60 | 175% |
Returns for 3 years | -15.04 | -9.02 | 167% |
Returns for 5 years | -1.76 | 35.10 | -5% |
Returns for 10 years | N/A | 74.28 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XPP | 18.71 | 2.26 | +13.74% |
ProShares Ultra FTSE China 50 | |||
CGUS | 32.53 | 2.60 | +8.69% |
Capital Group Core Equity ETF | |||
PFN | 7.23 | 0.27 | +3.88% |
PIMCO Income Strategy Fund II | |||
OPP | 8.35 | 0.23 | +2.83% |
RiverNorth/DoubleLine Strategic Opportunity Fund | |||
GEMD | 39.56 | 0.74 | +1.89% |
Goldman Sachs Access Emrg Mkts USD BdETF |